- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 05-30-2025 12:42pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 200.5M | IPO Year: | 2021 |
| Target Price: | $6.50 | AVG Volume (30 days): | 22.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.58 - $6.28 | Next Earning Date: | 05-06-2025 |
| Revenue: | $67,173,000 | Revenue Growth: | 4.66% |
| Revenue Growth (this year): | 15.88% | Revenue Growth (next year): | 24.07% |
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
Simply Wall St.
19 days ago
SOPHiA GENETICS First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
23 days ago
Sophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ...
Zacks
24 days ago
SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates
PR Newswire
24 days ago
SOPHiA GENETICS Reports First Quarter 2025 Results
GuruFocus.com
25 days ago
Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result
Simply Wall St.
a month ago
Promising Penny Stocks To Consider In April 2025
MT Newswires
a month ago
SOPHiA, AstraZeneca Expand Deployment of Liquid Biopsy Testing
PR Newswire
a month ago
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
Compare SOPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.